BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9570574)

  • 1. A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese.
    Horiuchi T; Nishizaka H; Kojima T; Sawabe T; Niho Y; Schneider PM; Inaba S; Sakai K; Hayashi K; Hashimura C; Fukumori Y
    J Immunol; 1998 Feb; 160(3):1509-13. PubMed ID: 9570574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology of C9 deficiency heterozygotes with an Arg95Stop mutation of the C9 gene in Japan.
    Kira R; Ihara K; Watanabe K; Kanemitsu S; Ahmed SU; Gondo K; Takeshita K; Hara T
    J Hum Genet; 1999; 44(2):109-11. PubMed ID: 10083734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Typing of the nt343C>T (R95X) allele of the C9 gene by PCR-SSP and the allele frequency of R95X in five ethnic populations.
    Tsujimura R; Nishimukai H; Okiura T; Fukumori Y; Tanabe R; Orimoto C; Ueda N
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S482-3. PubMed ID: 19261509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Founder effect of the C9 R95X mutation in Orientals.
    Khajoee V; Ihara K; Kira R; Takemoto M; Torisu H; Sakai Y; Guanjun J; Hee PM; Tokunaga K; Hara T
    Hum Genet; 2003 Mar; 112(3):244-8. PubMed ID: 12596049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsense mutation in exon 4 of human complement C9 gene is the major cause of Japanese complement C9 deficiency.
    Kira R; Ihara K; Takada H; Gondo K; Hara T
    Hum Genet; 1998 Jun; 102(6):605-10. PubMed ID: 9703418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membranoproliferative pattern of glomerular injury associated with complement component 9 deficiency due to Arg95Stop mutation.
    Miura T; Goto S; Iguchi S; Shimada H; Ueno M; Nishi S; Narita I
    Clin Exp Nephrol; 2011 Feb; 15(1):86-91. PubMed ID: 21057849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human complement C9 gene: identification of two mutations causing deficiency and revision of the gene structure.
    Witzel-Schlömp K; Späth PJ; Hobart MJ; Fernie BA; Rittner C; Kaufmann T; Schneider PM
    J Immunol; 1997 May; 158(10):5043-9. PubMed ID: 9144525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic bases of human complement C7 deficiency.
    Nishizaka H; Horiuchi T; Zhu ZB; Fukumori Y; Volanakis JE
    J Immunol; 1996 Nov; 157(9):4239-43. PubMed ID: 8892662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular bases for inherited human complement component C6 deficiency in two unrelated individuals.
    Nishizaka H; Horiuchi T; Zhu ZB; Fukumori Y; Nagasawa K; Hayashi K; Krumdieck R; Cobbs CG; Higuchi M; Yasunaga S; Niho Y; Volanakis JE
    J Immunol; 1996 Mar; 156(6):2309-15. PubMed ID: 8690922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies on C9 deficiency.
    Kitamura H; Nagaki K; Inai S
    J Clin Lab Immunol; 1981 Jul; 6(1):7-11. PubMed ID: 7265179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The occurrence of precipitating antibodies in transfused Japanese patients with hereditary ninth component of complement deficiency and frequency of C9 deficiency.
    Inaba S; Okochi K; Fukada K; Kinoshita S; Maeda Y; Yoshinari M
    Transfusion; 1987; 27(6):475-7. PubMed ID: 3686657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C9-R95X polymorphism in patients with neovascular age-related macular degeneration.
    Nishiguchi KM; Yasuma TR; Tomida D; Nakamura M; Ishikawa K; Kikuchi M; Ohmi Y; Niwa T; Hamajima N; Furukawa K; Terasaki H
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):508-12. PubMed ID: 22190594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of systemic lupus erythematosus in late component (C9) complement deficiency].
    Takeda I; Igarashi S; Nishimaki T; Kasukawa R
    Ryumachi; 1994 Jun; 34(3):628-32. PubMed ID: 8052928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis of human complement C8 alpha-gamma deficiency.
    Kojima T; Horiuchi T; Nishizaka H; Fukumori Y; Amano T; Nagasawa K; Niho Y; Hayashi K
    J Immunol; 1998 Oct; 161(7):3762-6. PubMed ID: 9759902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic detection of the silent allele (*Q0) in hereditary deficiencies of the human complement C6, C7, and C9 components.
    Alvarez V; Coto E; Setién F; Spath PJ; López-Larrea C
    Am J Med Genet; 1995 Feb; 55(4):408-13. PubMed ID: 7762578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary complement (C9) deficiency associated with dermatomyositis.
    Ichikawa E; Furuta J; Kawachi Y; Imakado S; Otsuka F
    Br J Dermatol; 2001 May; 144(5):1080-3. PubMed ID: 11359403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminal complement component deficiencies in Japan.
    Fukumori Y; Horiuchi T
    Exp Clin Immunogenet; 1998; 15(4):244-8. PubMed ID: 10072634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human complement C9 gene: structural analysis of the 5' gene region and genetic polymorphism studies.
    Witzel-Schlömp K; Rittner C; Schneider PM
    Eur J Immunogenet; 2001 Oct; 28(5):515-22. PubMed ID: 11881818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement component 9 deficiency is not a susceptibility factor for SLE.
    Kanemitsu S; Ihara K; Kira R; Kaku Y; Sakai K; Tsuzaka K; Takeuchi T; Hara T
    Lupus; 2000; 9(6):456-7. PubMed ID: 10981651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel nonsense mutation at Glu-631 in a Spanish family with complement component 7 deficiency.
    Horiuchi T; Ferrer JM; Serra P; Matamoros N; López-Trascasa M; Hashimura C; Niho Y
    J Hum Genet; 1999; 44(3):215-8. PubMed ID: 10319591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.